Time & Location
Nearly 74% of all overdose deaths linked to cocaine now involve synthetic opioids, such as fentanyl. This trend – multiple drugs used in combination – is part of the rapidly evolving overdose crisis. Xylazine, a non-opioid sedative commonly known as 'tranq,' is also increasingly detected in fentanyl-related deaths. In addition, there is an ongoing need for care and treatment for substance use disorders (SUD), particularly medically assisted treatment (MAT).
Our esteemed panel of experts delved into these issues and discuss solutions and strategies to reduce drug overdose rates. Speakers covered:
The latest federal priorities for addressing the overdose and addiction epidemic, including a focus on drugs used in combination and treatment efforts.
On-the-ground harm reduction efforts, including increasing access to naloxone, test strips, and syringe service programs.
Innovative approaches within health plans to combat SUD through prevention, mitigation, recovery, and treatment.
Cecelia Spitznas, PhD
Senior Science Policy Advisor at the Office of National Drug Control Policy in the White House
Overdose Prevention & Harm Reduction Coordinator at Prevention Point Philadelphia
Doug Henry, PhD
Vice President of Psychiatry and Behavioral Health at Allegheny Health Network
Closed captioning is available for this event.
More Related Content
Published on: August 21, 2023.